CPC has launched the MicroCNX series of aseptic connectors, designed to provide an efficient method of connecting tubing in small-format assemblies and an alternative to tube welding for small-volume closed processes.
“MicroCNX connectors are a critically important option for a range of bioprocessing, cell therapy and gene therapy workflows,” said Troy Ostreng, Senior Product Manager for CPC’s Biopharmaceutical Business. “Until now, cumbersome tube welding has been the only way to make sterile closed connections of very small-bore tubing. The MicroCNX connector represents a huge innovation for the industry.”
The connectors are specifically designed for small-volume processes involving widely 1.6mm, 2.4mm and 3.2mm tubing. These include sampling, seed train expansion and early cell culture processes involving shaker flasks and rocker tables.
“The MicroCNX series was designed to help manufacturers improve efficiencies and reduce time and total cost in creating closed systems that deliver reliable, reproducible results,” said Ostreng.
The company says its testing indicates making a sterile connection with its connector is up to four times faster than an operator using a tube welder. three-step "pinch-click-pull" process for using the connectors is aimed to require minimal training. With its connectors, the company says, there's no risk of faulty welds, welder breakdowns, or production delays due to weld equipment downtime.
Contrasting to tube welders, the compact product is also aimed to help biopharmaceutical and cell and gene therapy manufacturers make the most of existing cleanroom space. The connectors are incorporated into pre-made tubing assemblies, which ensures operators know where to make connections without guesswork, in accordance with cGMP.
